SCNI
Scinai Immunotherapeutics
SCNI
SCNI
14 hedge funds and large institutions have $11.5M invested in Scinai Immunotherapeutics in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+6
Holders Change %
+75%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
4
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
JSMC
Jess S. Morgan & Co
Los Angeles,
California
|
$1.6M |
2 |
Renaissance Technologies
New York
|
$1.22M |
3 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
$207K |
4 |
Morgan Stanley
New York
|
$94K |
5 |
UBS Group
Zurich,
Switzerland
|
$43K |
Top Sellers
1 |
II
Ibex Investors
Denver,
Colorado
|
$7.47M |
2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$78K |
3 |
![]()
JPMorgan Chase & Co
New York
|
$0 |